A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

NCT ID: NCT04961996

Last Updated: 2025-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

4200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-27

Study Completion Date

2035-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with endocrine therapy of physician's choice in participants with medium- and high-risk Stage I-III histologically confirmed estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative early breast cancer.

In addition, an open-label exploratory substudy will explore the safety and efficacy of giredestrant in combination with abemaciclib in a subset of the primary study population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm A: Giredestrant

Group Type EXPERIMENTAL

Giredestrant

Intervention Type DRUG

Giredestrant 30 milligrams (mg) will be administered orally once a day (QD) on Days 1-28 of each 28-day cycle for 5 years or until disease recurrence or unacceptable toxicity (whichever occurs first).

LHRH Agonist

Intervention Type DRUG

A luteinizing hormone-releasing hormone (LHRH) agonist will be administered to male participants and premenopausal/perimenopausal participants according to local prescribing information. The investigator may determine and supply the appropriate LHRH agonist locally approved for use in breast cancer.

Arm B: Endocrine Therapy of Physician's Choice

Group Type ACTIVE_COMPARATOR

Endocrine Therapy of Physician's Choice

Intervention Type DRUG

The endocrine therapy of physician's choice (TPC) is limited to tamoxifen or one of the specified third generation aromatase inhibitors: letrozole, anastrozole, or exemestane. Participants will receive TPC daily on Days 1-28 of each 28-day cycle for 5 years or until disease recurrence or unacceptable toxicity (whichever occurs first). Continuing TPC after 5 years is at the discretion of the investigator and per local standard of care. Dose administration of TPC should be performed in accordance with the local prescribing information for the respective product.

LHRH Agonist

Intervention Type DRUG

A luteinizing hormone-releasing hormone (LHRH) agonist will be administered to male participants and premenopausal/perimenopausal participants according to local prescribing information. The investigator may determine and supply the appropriate LHRH agonist locally approved for use in breast cancer.

Substudy: Giredestrant + Abemaciclib, Then Giredestrant

In this substudy, participants will receive giredestrant in combination with abemaciclib for up to 2 years. Participants will continue with giredestrant monotherapy for an additional 3 years in order to complete a total of 5 years on study treatment.

Group Type EXPERIMENTAL

Giredestrant

Intervention Type DRUG

Giredestrant 30 milligrams (mg) will be administered orally once a day (QD) on Days 1-28 of each 28-day cycle for 5 years or until disease recurrence or unacceptable toxicity (whichever occurs first).

Abemaciclib

Intervention Type DRUG

Abemaciclib 150 mg will be administered orally (PO) twice a day (BID) on Days 1-28 during each 28-day cycle for 2 years or until disease recurrence or unacceptable toxicity (whichever occurs first).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Giredestrant

Giredestrant 30 milligrams (mg) will be administered orally once a day (QD) on Days 1-28 of each 28-day cycle for 5 years or until disease recurrence or unacceptable toxicity (whichever occurs first).

Intervention Type DRUG

Endocrine Therapy of Physician's Choice

The endocrine therapy of physician's choice (TPC) is limited to tamoxifen or one of the specified third generation aromatase inhibitors: letrozole, anastrozole, or exemestane. Participants will receive TPC daily on Days 1-28 of each 28-day cycle for 5 years or until disease recurrence or unacceptable toxicity (whichever occurs first). Continuing TPC after 5 years is at the discretion of the investigator and per local standard of care. Dose administration of TPC should be performed in accordance with the local prescribing information for the respective product.

Intervention Type DRUG

LHRH Agonist

A luteinizing hormone-releasing hormone (LHRH) agonist will be administered to male participants and premenopausal/perimenopausal participants according to local prescribing information. The investigator may determine and supply the appropriate LHRH agonist locally approved for use in breast cancer.

Intervention Type DRUG

Abemaciclib

Abemaciclib 150 mg will be administered orally (PO) twice a day (BID) on Days 1-28 during each 28-day cycle for 2 years or until disease recurrence or unacceptable toxicity (whichever occurs first).

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

GDC-9545 RO7197597 RG6171

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Documented estrogen receptor (ER)-positive and HER2-negative breast tumor, as assessed locally on a primary disease specimen
* Participants who have multicentric (the presence of two of more tumor foci within different quadrants of the same breast) and/or multifocal (the presence of two or more tumor foci within a single quadrant of the breast) breast cancer are also eligible if all examined tumors meet pathologic criteria for ER positivity and HER2 negativity
* Participants must have undergone definitive surgery of their primary breast tumor(s) and axillary lymph nodes (axillary lymph node dissection \[ALND\] and/or sentinel lymph node biopsy \[SLNB\])
* Participants who received or will be receiving adjuvant chemotherapy must have completed adjuvant chemotherapy prior to randomization. Participants may also have received neoadjuvant chemotherapy. A washout period of at least 21 days is required between last adjuvant chemotherapy dose and randomization.
* Resolution of all acute toxic effects of prior anti-cancer therapy or surgical procedures to NCI CTCAE v5.0 Grade 1 or better (except alopecia, Grade ≤2 peripheral neuropathy, arthralgia or other toxicities not considered a safety risk for the participant per the investigator's judgment)
* Participants have received (neo)adjuvant chemotherapy and/or had surgery and had no prior endocrine therapy are eligible, provided that they are enrolled within 12 months following definitive breast cancer surgery
* Participants who have confirmed availability of an untreated primary breast tumor tissue specimen suitable for biomarker testing (i.e., representative archived formalin-fixed, paraffin-embedded \[FFPE\] tissue block \[preferred\] or 15-20 slides containing unstained, freshly cut, serial sections), with associated de-identified pathology report is required. Although 15-20 slides are preferred, if only 10-14 slides are available, the individual may still be eligible for the study.
* Participants with node-positive and node-negative disease are eligible provided they meet additional risk criteria as defined in the protocol
* Eastern Cooperative Oncology Group (ECOG) Performance Status 0, 1, or 2
* Able and willing to swallow, retain, and absorb oral medication
* Adequate organ function



\- Patients who received adjuvant radiotherapy must have completed radiotherapy prior to enrollment, and patients must have recovered (to Grade ≤1) from the acute effects of radiotherapy. A washout period of at least 14 days is required between end of radiotherapy and enrollment.

Exclusion Criteria

* Pregnant or breastfeeding, or intending to become pregnant during the study or within 10 days after the final dose of giredestrant, or within the time period specified per local prescribing guidelines after the final dose of the endocrine therapy of physician's choice
* Received treatment with investigational therapy within 28 days prior to initiation of study treatment or is currently enrolled in any other type of medical research judged by the sponsor not to be scientifically or medically compatible with this study
* Receiving or planning to receive a CDK4/6 inhibitor as (neo)adjuvant therapy. A short course of up to 12 weeks of neoadjuvant or adjuvant treatment with CDK4/6 inhibitor therapy prior to randomization is allowed.
* Active cardiac disease or history of cardiac dysfunction
* Diagnosed with Stage IV breast cancer
* A history of any prior (ipsilateral and/or contralateral) invasive breast cancer or ductal carcinoma in situ (DCIS). Participants with a history of contralateral DCIS treated by only local regional therapy at any time may be eligible.
* A history of any other malignancy within 3 years prior to screening, except for appropriately treated carcinoma in situ of the cervix, nonmelanoma skin carcinoma, or Stage I uterine cancer
* Any prior endocrine treatment with selective ER modulators (e.g., tamoxifen), degraders, or aromatase inhibitors. A short course of neoadjuvant or adjuvant endocrine therapy (up to 12 weeks) is allowed.
* Clinically significant liver disease consistent with Child-Pugh Class B or C, including active hepatitis (e.g., hepatitis B virus \[HBV\] or hepatitis C virus \[HCV\]), current alcohol abuse, cirrhosis, or positive test for viral hepatitis
* Treatment with strong CYP3A4 inhibitors or inducers within 14 days or 5 drug elimination half-lives (whichever is longer) prior to initiation of study treatment
* Known allergy or hypersensitivity to any of the study drugs or any of their excipients
* Pre- and perimenopausal participants or male participants who have a known hypersensitivity to LHRH agonists
* A documented history of hemorrhagic diathesis, coagulopathy, or thromboembolism
* Renal dysfunction that requires dialysis
* A major surgical procedure unrelated to breast cancer within 28 days prior to randomization
* A serious infection requiring oral or IV antibiotics within 14 days prior to screening or other clinically significant infection (e.g., COVID-19) within 14 days prior to screening
* Any serious medical condition or abnormality in clinical laboratory tests that, in the investigator's judgment, precludes an individual's safe participation in and completion of the study
* Unable or unwilling to comply with the requirements of the protocol in the opinion of the investigator


Potential participants are excluded from the substudy if any criteria from t\\he primary study or the following criteria apply:

* Prior participation in the GO42784 primary study
* Received a CDK4/6i as (neo)adjuvant therapy prior to enrollment
* Treatment with moderate CYP3A inducers, strong CYP3A inducers or strong CYP3A inhibitors within 14 days or 5 drug elimination half-lives (whichever is longer) prior to initiation of study treatment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital HM Nuestra Señora de la Esperanza

Santiago de Compostela, Burgos, Spain

Site Status

Hospital de Jerez

Jerez de la Frontera, Cadiz, Spain

Site Status

Consorcio Hospitalario Provincial de Castellon

Castellon de LA Plana/castello de LA Plana, Castellon, Spain

Site Status

Hospital Universitario de Donostia

Donostia / San Sebastian, Guipuzcoa, Spain

Site Status

Hospital Universitario A Coruña

A Coruña, LA Coruna, Spain

Site Status

CHUS H Clinico U de Santiago

Santiago de Compostela, LA Coruna, Spain

Site Status

Southern Cancer Center

Daphne, Alabama, United States

Site Status

CBCC Global Research Inc., at Comprehensive Blood and Cancer Center

Bakersfield, California, United States

Site Status

Arrowhead Regional Medical Center

Colton, California, United States

Site Status

Cancer and Blood Specialty Clinic

Fountain Valley, California, United States

Site Status

St Joseph Heritage Healthcare

Fullerton, California, United States

Site Status

Long Beach Memorial Medical Center

Long Beach, California, United States

Site Status

Keck Medicine of USC ? Newport Beach

Newport Beach, California, United States

Site Status

The Center for Cancer Prevention and Treatment at St.Joseph Hospital of Orange

Orange, California, United States

Site Status

Stanford University Medical Center

Palo Alto, California, United States

Site Status

Kaiser Permanente - San Diego

San Diego, California, United States

Site Status

Stanford Cancer Center South Bay

San Jose, California, United States

Site Status

Sansum Clinic

Santa Barbara, California, United States

Site Status

UCLA Hematology/Oncology

Santa Monica, California, United States

Site Status

Torrance Memorial Physician Network/Cancer Care

Torrance, California, United States

Site Status

Kaiser Permanente - Vallejo

Vallejo, California, United States

Site Status

Rocky Mountain Cancer Centers (Longmont) - USOR

Longmont, Colorado, United States

Site Status

Stamford Hospital

Stamford, Connecticut, United States

Site Status

University of Florida

Gainesville, Florida, United States

Site Status

Memorial Healthcare System - Memorial Regional Hospital

Hollywood, Florida, United States

Site Status

Baptist - MD Anderson Cancer Center

Jacksonville, Florida, United States

Site Status

Miami Cancer Institute of Baptist Health, Inc.

Miami, Florida, United States

Site Status

Mount Sinai Comprehensive Cancer Center

Miami Beach, Florida, United States

Site Status

Orlando Health Cancer Institute

Orlando, Florida, United States

Site Status

Miami Cancer Institute-Plantation

Plantation, Florida, United States

Site Status

Memorial Health University Cancer Center

Savannah, Georgia, United States

Site Status

University of Chicago Hospital

Chicago, Illinois, United States

Site Status

Elmhurst Cancer Center

Elmhurst, Illinois, United States

Site Status

Edward Cancer Center Plainfield

Plainfield, Illinois, United States

Site Status

Duly Health and Care

Tinley Park, Illinois, United States

Site Status

Oncology Associates at Mercy Medical Center

Cedar Rapids, Iowa, United States

Site Status

University of Iowa

Iowa City, Iowa, United States

Site Status

Cancer Center of Kansas - Kingman

Kingman, Kansas, United States

Site Status

University of Kentucky

Lexington, Kentucky, United States

Site Status

Norton Cancer Institute - MDC

Louisville, Kentucky, United States

Site Status

University Medical Center New Orleans

New Orleans, Louisiana, United States

Site Status

UPMC Western Maryland - Schwab Family Cancer Center

Cumberland, Maryland, United States

Site Status

University of Maryland

Towson, Maryland, United States

Site Status

Lahey Clinic Med Ctr

Burlington, Massachusetts, United States

Site Status

University Of Michigan

Ann Arbor, Michigan, United States

Site Status

Metro-Minnesota Community Oncology Research Consortium

Saint Louis Park, Minnesota, United States

Site Status

University of Missouri-Columbia

Columbia, Missouri, United States

Site Status

St. Vincent Frontier Cancer Center

Billings, Montana, United States

Site Status

Nebraska Cancer Specialists

Omaha, Nebraska, United States

Site Status

Comprehensive Cancer Centers of Nevada

Las Vegas, Nevada, United States

Site Status

Hunterdon Hematology Oncology

Flemington, New Jersey, United States

Site Status

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, United States

Site Status

New York University Cancer Cen

New York, New York, United States

Site Status

Stony Brook Univ Cancer Ctr

Stony Brook, New York, United States

Site Status

Messino Cancer Centers

Asheville, North Carolina, United States

Site Status

Levine Cancer Institute

Charlotte, North Carolina, United States

Site Status

Rex Cancer Center

Raleigh, North Carolina, United States

Site Status

Atrium Health Wake Forest Baptist Medical Center - PPDS

Winston-Salem, North Carolina, United States

Site Status

Aultman Hospital

Canton, Ohio, United States

Site Status

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Site Status

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

Columbus NCORP

Columbus, Ohio, United States

Site Status

Stefanie Spielman Comprehensive Breast Center

Columbus, Ohio, United States

Site Status

Oncology Associates of Oregon, P.C.

Eugene, Oregon, United States

Site Status

Kaiser Permanente-Northwest Region

Portland, Oregon, United States

Site Status

Pinnacle Health

Harrisburg, Pennsylvania, United States

Site Status

Penn State Univ. Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

Site Status

Allegheny Cancer Center

Pittsburgh, Pennsylvania, United States

Site Status

Magee Womens Hospital

Pittsburgh, Pennsylvania, United States

Site Status

Reading Hospital

West Reading, Pennsylvania, United States

Site Status

Women & Infants Hospital

Providence, Rhode Island, United States

Site Status

Avera Cancer Institute

Sioux Falls, South Dakota, United States

Site Status

West Cancer Center & Research Institute

Germantown, Tennessee, United States

Site Status

Texas Oncology, P.A. - El Paso

El Paso, Texas, United States

Site Status

Texas Oncology (Flower Mound) - USOR

Flower Mound, Texas, United States

Site Status

Texas Oncology-Fort Worth Cancer Center

Fort Worth, Texas, United States

Site Status

Baylor College of Medicine Medical Center

Houston, Texas, United States

Site Status

Houston Methodist Cancer Center

Houston, Texas, United States

Site Status

Joe Arrington Cancer Research & Treatment Center

Lubbock, Texas, United States

Site Status

Texas Oncology (McAllen) - USOR

McAllen, Texas, United States

Site Status

Texas Oncology McKinney

McKinney, Texas, United States

Site Status

Texas Oncology (Tyler) - USOR

Tyler, Texas, United States

Site Status

Texas Oncology (Waco) - USOR

Waco, Texas, United States

Site Status

Centra Alan B. Pearson Regional Cancer Center

Lynchburg, Virginia, United States

Site Status

Bon Secours Mercy Health

Midlothian, Virginia, United States

Site Status

Virginia Oncology Associates

Norfolk, Virginia, United States

Site Status

Virginia Commonwealth University - Massey Cancer Center

Richmond, Virginia, United States

Site Status

Oncology and Hematology Associates of Southwest Virginia, Inc.,-Blacksburg

Roanoke, Virginia, United States

Site Status

Swedish Cancer Institute

Seattle, Washington, United States

Site Status

West Virginia University Hospitals Inc

Morgantown, West Virginia, United States

Site Status

University of Wisconsin

Madison, Wisconsin, United States

Site Status

Froedtert and The Medical College of Wisconsin

Milwaukee, Wisconsin, United States

Site Status

Centro de Investigaciones Médicas y Desarrollo LC S.R.L

Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina

Site Status

Fundacion Intectus

Bariloche, Río Negro Province, Argentina

Site Status

Hospital Italiano Regional del Sur

Bahía Blanca, , Argentina

Site Status

Instituto de Investigaciones Clinicas-Mar del Plata

Buenos Aires, , Argentina

Site Status

Instituto de Investigaciones Metabólicas (IDIM)

Buenos Aires, , Argentina

Site Status

Centro Oncologico Korben

Caba, , Argentina

Site Status

Fundacion Medica de Rio Negro Y Nuequen

Cipolletti, , Argentina

Site Status

Consultorios Médicos Dr. Doreski

Ciudad Autonoma Buenos Aires, , Argentina

Site Status

Sanatorio Allende Servicio Nefrología

Córdoba, , Argentina

Site Status

Centro Medico Privado CEMAIC

Córdoba, , Argentina

Site Status

Centro Oncologico Riojano Integral (CORI)

La Rioja, , Argentina

Site Status

Centro de Investigaciones Medicas Mar Del Plata

Mar del Plata, , Argentina

Site Status

Hospital Privado de La Comunidad

Mar del Plata, , Argentina

Site Status

Centro de Investigacion Pergamino SA

Pergamino, , Argentina

Site Status

Instituto de Especialidades de la Salud Rosario - Clínica del Tórax

Rosario, , Argentina

Site Status

Sanatorio Parque de Rosario

Rosario, , Argentina

Site Status

Instituto de Oncologia de Rosario

Rosario, , Argentina

Site Status

Centro Polivalente de Asistencia e Investigacion Clinica - CER San Juan

San Juan, , Argentina

Site Status

Centro Médico Privado de Reumatología

San Miguel de Tucumán, , Argentina

Site Status

Centro Medico San Roque

San Miguel de Tucumán, , Argentina

Site Status

Organizacion Medica de Investigacion

San Nicolás, , Argentina

Site Status

Fundación Ars Medica

San Salvador de Jujuy, , Argentina

Site Status

Centro de Investigación Clínica ? Clínica Viedma

Viedma, , Argentina

Site Status

Campbelltown Hospital

Campbelltown, New South Wales, Australia

Site Status

Liverpool Hospital

Liverpool, New South Wales, Australia

Site Status

Westmead Hospital

Northmead, New South Wales, Australia

Site Status

Mater Hospital

Wollstonecraft, New South Wales, Australia

Site Status

Mater Cancer Care Centre

Brisbane, Queensland, Australia

Site Status

Cairns Hospital

Cairns, Queensland, Australia

Site Status

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

Site Status

Royal Adelaide Hospital

Adelaide, South Australia, Australia

Site Status

St Andrews Medical Centre

Adelaide, South Australia, Australia

Site Status

Flinders Medical Centre

Bedford Park, South Australia, Australia

Site Status

Ashford Cancer Centre Research

Kurralta Park, South Australia, Australia

Site Status

ICON Cancer Care Hobart

Hobart, Tasmania, Australia

Site Status

Bendigo Hospital

Bendigo, Victoria, Australia

Site Status

Northern Hospital

Epping, Victoria, Australia

Site Status

Frankston Hospital

Frankston, Victoria, Australia

Site Status

Maroondah Hospital

Ringwood East, Victoria, Australia

Site Status

Goulburn Valley Health

Shepparton, Victoria, Australia

Site Status

Sunshine Hospital

St Albans, Victoria, Australia

Site Status

South West Healthcare

Warrnambool, Victoria, Australia

Site Status

Ballarat Oncology & Haematology

Wendouree, Victoria, Australia

Site Status

Sir Charles Gairdner Hospital

Nedlands, Western Australia, Australia

Site Status

Medizinische Universitat Innsbruck

Innsbruck, , Austria

Site Status

Ordensklinikum Linz GmbH

Linz, , Austria

Site Status

LKH Rankweil, Interne E

Rankweil, , Austria

Site Status

Universitätsklinikum Salzburg

Salzburg, , Austria

Site Status

Universitätsklinikum St. Pölten

Sankt Pölten, , Austria

Site Status

A.ö. Krankenhaus der Barmherzigen Brüder

Sankt Veit im Pongau, , Austria

Site Status

Oö. Gesundheits- und Spitals-AG/LKH Steyr

Steyr, , Austria

Site Status

Medizinische Universitat Wien Medical University of Vienna

Vienna, , Austria

Site Status

Klinikum Wels-Grieskirchen GmbH

Wels, , Austria

Site Status

Institute Jules Bordet

Belgium, , Belgium

Site Status

Grand Hopital de Charleroi asbl

Charleroi, , Belgium

Site Status

UZ Leuven

Leuven, , Belgium

Site Status

CH de l'Ardenne (Libramont)

Libramont, , Belgium

Site Status

Centre Hospitalier Chrétien MontLégia

Liège, , Belgium

Site Status

CHR de la Citadelle, Pharmacie

Liège, , Belgium

Site Status

Chu Sart Tilman

Liège, , Belgium

Site Status

Clinique Sainte-Elisabeth

Namur, , Belgium

Site Status

Cliniques Universitaires UCL de Mont-Godinne

Namur, , Belgium

Site Status

GZA Ziekenhuizen Antwerpen campus Sint-Augustinus

Wilrijk, , Belgium

Site Status

Clinical Center Banja Luka

Banja Luka, , Bosnia and Herzegovina

Site Status

Clinical Hospital Mostar

Mostar, , Bosnia and Herzegovina

Site Status

University Clinical Center Tuzla

Tuzla, , Bosnia and Herzegovina

Site Status

Centro Odonito Medico Linus Pauling - Clinica de O

Salvador, Estado de Bahia, Brazil

Site Status

Nucleo de Oncologia da Bahia - NOB

Salvador, Bahia, Estado de Bahia, Brazil

Site Status

Centro de Oncologia da Bahia

Salvador/BA, Estado de Bahia, Brazil

Site Status

Hospital Araujo Jorge

Goiânia, Goiás, Brazil

Site Status

Cenantron - Centro Avancado de Tratamento Oncologico

Belo Horizonte, Minas Gerais, Brazil

Site Status

Oncoclinicas do Brasil Servicos Medicos As

Belo Horizonte, Minas Gerais, Brazil

Site Status

Hospital de Clinicas de Porto Alegre HCPA PPDS

Pôrto Alegre, Pará, Brazil

Site Status

Hospital do Cancer de Pernambuco - HCP

Recife, Pernambuco, Brazil

Site Status

Universidade de Caxias do Sul - Rio Grande do Sul

Caixas Do Sul, Rio Grande do Sul, Brazil

Site Status

ONCOSITE Centro de Pesquisa Clínica Em Oncologia

Ijuí, Rio Grande do Sul, Brazil

Site Status

Hospital Bruno Born

Lajeado, Rio Grande do Sul, Brazil

Site Status

Hospital São Vicente de Paulo X

Passo Fundo, Rio Grande do Sul, Brazil

Site Status

Hospital Moinhos de Vento

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Irmandade Da Santa Casa de Misericordia de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital Mae de Deus

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital Sao Lucas - PUCRS

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital Nossa Senhora da Conceição

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

*X*Fundação Pio XII Hospital de Câncer de Barretos

Barretos, São Paulo, Brazil

Site Status

Hospital Amaral Carvalho

Jaú, São Paulo, Brazil

Site Status

Instituto de Oncologia Clínica de Piracicaba

Piracicaba, São Paulo, Brazil

Site Status

Faculdade de Medicina do ABC - FMABC

Santo André, São Paulo, Brazil

Site Status

Fundação Faculdade Regional de Medicina de São José do Rio Preto

São José do Rio Preto, São Paulo, Brazil

Site Status

Instituto do Cancer do Estado de Sao Paulo - ICESP

São Paulo, São Paulo, Brazil

Site Status

Instituto Nacional de Cancer - INCa

Rio de Janeiro, , Brazil

Site Status

Clinica de Pesquisas e Centro de Estudos Oncologia Ginecologica e Mamaria Ltda

São Paulo, , Brazil

Site Status

Onco Star Sp Oncologia Ltda

São Paulo, , Brazil

Site Status

Complex Oncology Center Burgas

Burgas, , Bulgaria

Site Status

Multiprofile Hospital for Active Treatment Uni Hospital

Panagyurishte, , Bulgaria

Site Status

Arthur J.E. Child Comprehensive Cancer Center-Calgary

Calgary, Alberta, Canada

Site Status

Cross Cancer Institute

Edmonton, Alberta, Canada

Site Status

British Columbia Cancer Agency

Vancouver, British Columbia, Canada

Site Status

The Moncton Hospital

Moncton, New Brunswick, Canada

Site Status

Sault Area Hospital

Sault Ste. Marie, Ontario, Canada

Site Status

Centre Integre Universitaire de Sante et de Services Sociaux du Saguenay Lac Saint Jean

Chicoutimi, Quebec, Canada

Site Status

Hopital Charles Le Moyne

Greenfield Park, Quebec, Canada

Site Status

CIUSSS-de-l?Est-de-l?Île-de-Montréal

Montreal, Quebec, Canada

Site Status

CHUM

Montreal, Quebec, Canada

Site Status

Sir Mortimer B Davis Jewish General Hospital

Montreal, Quebec, Canada

Site Status

McGill University Health Center

Montreal, Quebec, Canada

Site Status

St-Jérome Medical Research, Inc.

Saint-Jérôme, Quebec, Canada

Site Status

Centre Hospitalier Universitaire de Sherbrooke

Sherbrooke, Quebec, Canada

Site Status

Allan Blair Cancer Centre

Regina, Saskatchewan, Canada

Site Status

CHU de Quebec-Universite Laval

Québec, , Canada

Site Status

Fundacion Arturo Lopez Perez (FALP) - Providencia - Jose Manuel Infante 805

Providencia, Región-MetropolitanadeSantiago, Chile

Site Status

IC La Serena Research SpA

La Serena, , Chile

Site Status

Patagonia Research

Port Montt, , Chile

Site Status

Centro de Estudios Clínicos SAGA SpA

Providencia, , Chile

Site Status

Servicios Médicos URUMED SpA

Rancagua, , Chile

Site Status

Oncovida - Santiago

Santiago, , Chile

Site Status

Centro de Estudios Clinicos E Investigaciones Medicas

Santiago, , Chile

Site Status

Icegclinic

Santiago, , Chile

Site Status

Medwal

Santiago, , Chile

Site Status

James Lind Centro de Investigación Del Cáncer

Temuco, , Chile

Site Status

Oncocentro Apys

Viña del Mar, , Chile

Site Status

Centro de Investigaciones Clinicas Viña del Mar

Viña del Mar, , Chile

Site Status

Henan Cancer Hospital

Zhengzhou, Henan, China

Site Status

Hunan Cancer Hospital

Changsha, Hunan, China

Site Status

Jiangxi Cancer Hospital

Nanchang, Jiangxi, China

Site Status

The First Hospital of Jilin University

Changchun, Jilin, China

Site Status

West China Hospital, Sichuan University

Chengdu, Sichuan, China

Site Status

Peking University People's Hospital

Beijing, , China

Site Status

Jilin Cancer Hospital

Changchun, , China

Site Status

The Second Affiliated Hospital of Dalian Medical University

Dalian, , China

Site Status

Fujian Provincial Cancer Hospital

Fuzhou, , China

Site Status

Guangdong Provincial Maternity and Child Care Cent

Guangzhou, , China

Site Status

Sun yat-sen University Cancer Center

Guangzhou, , China

Site Status

The First Affiliated Hospital of College of Medicine, Zhejiang University

Hangzhou, , China

Site Status

The Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, , China

Site Status

Zhejiang Cancer Hospital

Hangzhou, , China

Site Status

Harbin Medical University Cancer Hospital

Harbin, , China

Site Status

Anhui Province Cancer Hospital

Hefei, , China

Site Status

Jinan Central Hospital

Jinan, , China

Site Status

Yunnan Cancer Hospital

Kunming, , China

Site Status

Linyishi Cancer Hospital

Linyi, , China

Site Status

The Third Hospital of Nanchang

Nanchang, , China

Site Status

Guangxi Cancer Hospital of Guangxi Medical University

Nanning, , China

Site Status

The Second People's Hospital of Neijiang

Neijiang, , China

Site Status

Fudan University Shanghai Cancer Center

Shanghai, , China

Site Status

Shengjing Hospital of China Medical University

Shenyang, , China

Site Status

The Fourth Hospital of Hebei Medical University

Shijiazhuang, , China

Site Status

Tianjin Medical University Cancer Institute & Hospital

Tianjin, , China

Site Status

Wenzhou Medical College - The First Affiliated Hospital GCP

Wenzhou, , China

Site Status

Union Hospital Tongji Medical College Huazhong University of Science and Technology

Wuhan, , China

Site Status

Tongji Hospital Tongji Medical College Huazhong University of Science and Technology

Wuhan, , China

Site Status

Hubei Cancer Hospital

Wuhan, , China

Site Status

Air Force Military Medical University Xijing Hospital

Xi'an, , China

Site Status

First Affiliated Hospital of Medical College of Xi'an Jiaotong University

Xi'an, , China

Site Status

The First Affiliated Hospital of Xiamen University

Xiamen, , China

Site Status

The Affiliated Hospital of Xuzhou Medical University

Xuzhou, , China

Site Status

Oncomedica S.A.

Montería, Departamento de Córdoba, Colombia

Site Status

Hemato Oncólogos S.A

Cali, , Colombia

Site Status

FOSCAL

Floridablanca, , Colombia

Site Status

Consultorio Oncologico-Hospital Metropolitano Linc

Moravia, , Costa Rica

Site Status

Metropolitano Research Institute Lindora

San José, , Costa Rica

Site Status

Centro de Cáncer y Hematología

San José, , Costa Rica

Site Status

Instituto de Investigación en Ciencias Médicas S.A.

San José, , Costa Rica

Site Status

Clinical Hospital Centre Osijek

Osijek, , Croatia

Site Status

General Hospital Pula

Pula, , Croatia

Site Status

University Hospital of Split

Split, , Croatia

Site Status

General Hospital Varazdin

Varaždin, , Croatia

Site Status

Clinical Hospital Sestre Milosrdnice

Zagreb, , Croatia

Site Status

Klinicki bolnicki centar Zagreb

Zagreb, , Croatia

Site Status

Fakultni nemocnice Olomouc

Ostrava - Poruba, , Czechia

Site Status

Fakultni nemocnice Kralovske Vinohrady

Prague, , Czechia

Site Status

Vseobecna fakultni nemocnice v Praze

Prague, , Czechia

Site Status

Fakultni Thomayerova Nemocnice

Prague, , Czechia

Site Status

Mansoura University Hospital

Al Mansurah, , Egypt

Site Status

Alexandria Uni

Alexandria, , Egypt

Site Status

Medical Technology Center for Research and Services

Alexandria, , Egypt

Site Status

Kasr Al Ainy School of Medicine-Cairo University

Cairo, , Egypt

Site Status

Ain Shams University Hospital

Cairo, , Egypt

Site Status

Gustave Roussy International Egypt Hospital

Fostat, , Egypt

Site Status

Sohag Oncology Center

Markaz Sohag, , Egypt

Site Status

Helsingin yliopistollinen keskussairaala

Helsinki, , Finland

Site Status

Tampereen yliopistollinen sairaala

Tampere, , Finland

Site Status

Turun Yliopistollinen Keskussairaala

Turku, , Finland

Site Status

Centre Francois Baclesse

Caen, Calvados, France

Site Status

Clinique Clémentville

Montpellier, Hérault, France

Site Status

Sas Clinique De L Europe - Amiens

Amiens, , France

Site Status

Hopital d'Argenteuil

Argenteuil, , France

Site Status

Centre Hospitalier Regional Universitaire de Brest - Hopital de la Cavale Blanche

Brest, , France

Site Status

Institut Daniel Hollard

Grenoble, , France

Site Status

Centre Hospitalier Departemental de Vendee

La Roche-sur-Yon, , France

Site Status

Centre de cancérologie de la Sarthe - Aile B

Le Mans, , France

Site Status

Centre Oscar Lambret

Lille, , France

Site Status

CHU Dupuytren

Limoges, , France

Site Status

Hôpital Privé Clairval

Marseille, , France

Site Status

Clinique Catherine de Sienne

Nantes, , France

Site Status

Hopital Universitaire Pitie Salpetriere

Paris, , France

Site Status

Hopital Tenon

Paris, , France

Site Status

Institut Curie

Paris, , France

Site Status

Hopital Saint Louis

Paris, , France

Site Status

Hôpital Européen Georges Pompidou

Paris, , France

Site Status

Hopital privé des Côtes Armor

Plérin, , France

Site Status

EDOG - Centre Eugene Marquis Centre Regional de Lutte Contre Le Cancer - PPDS

Rennes, , France

Site Status

Centre Henri Becquerel

Rouen, , France

Site Status

Curie Saint Cloud

Saint-Cloud, , France

Site Status

Institut de Cancérologie Strasbourg Europe

Strasbourg, , France

Site Status

Institut Gustave Roussy

Villejuif, , France

Site Status

High Technology Hospital MedCenter Ltd

Batumi, , Georgia

Site Status

Acad. F. Todua Medical Center

Tbilisi, , Georgia

Site Status

Ltd Israel-Georgia Medical Research Clinic Helsicore

Tbilisi, , Georgia

Site Status

LTD Health House

Tbilisi, , Georgia

Site Status

Institute of Clinical Oncology LTD

Tbilisi, , Georgia

Site Status

LTD TIM, Tbilisi Institute of Medicine

Tbilisi, , Georgia

Site Status

Multiprofile Clinic Consilium Medulla

Tbilisi, , Georgia

Site Status

Hämatologisch/onkologische Gemeinschaftspraxis

Augsburg, , Germany

Site Status

Ambulantes Tumorzentrum Spandau

Berlin, , Germany

Site Status

Lübecker Onkologische Schwerpunktpraxis

Bonn, , Germany

Site Status

Klinikum Chemnitz gGmbH

Chemnitz, , Germany

Site Status

Universitatsklinikum Erlangen

Erlangen, , Germany

Site Status

KEM/Evang. Kliniken Essen Mitte gGmbH

Essen, , Germany

Site Status

Franziskus-Hospital Harderberg

Georgsmarienhütte, , Germany

Site Status

SRH Wald-Klinikum Gera

Gera, , Germany

Site Status

Mammazentrum Hamburg am Krankenhaus Jerusalem

Hamburg, , Germany

Site Status

Gynäkologisch Onkologische Praxis Hannover

Hanover, , Germany

Site Status

Vincentius-Diakonissen-Kliniken gAG

Karlsruhe, , Germany

Site Status

Facharztpraxis für Gynäkologie und Geburtshilfe PD Dr. med. Christian Kurbacher

Lübeck, , Germany

Site Status

Universitätsmedizin Mainz

Mainz, , Germany

Site Status

Klinikum Mannheim GmbH Universitätsklinikum

Mannheim, , Germany

Site Status

Praxis fuer gynaekologische onkologie Prof. Dr. me

Mönchengladbach, , Germany

Site Status

Hämatologie und Onkologie Ravensburg / Wangen

Ravensburg, , Germany

Site Status

Leopoldina Krankenhaus Schweinfurt

Schweinfurt, , Germany

Site Status

Praxis fur Haematologie und Internistische Onkologie

Velbert, , Germany

Site Status

European Interbalkan Medical Center

Pylaia, Thessaloniki, Greece

Site Status

Henry Dunant Hospital

Athens, , Greece

Site Status

University of Athens, Hematological Clinic,

Athens, , Greece

Site Status

Aretaieio Hospital of Athens

Athens, , Greece

Site Status

Sotiria Chest Hospital of Athens

Athens, , Greece

Site Status

General Oncology Hospital Kifissias "Oi Agioi Anargyroi"

Athens, , Greece

Site Status

Attikon University General Hospital

Chaïdári, , Greece

Site Status

Metropolitan General Hospital

Cholargós, , Greece

Site Status

Metropolitan Hospital First Oncology Clinic

Faliro, , Greece

Site Status

University General Hospital of Heraklion

Heraklion, , Greece

Site Status

University General Hospital of Ioannina

Ioannina, , Greece

Site Status

University General Hospital of Larissa

Larissa, , Greece

Site Status

IASO Obstetrics Gynecology Clinic

Marousi, , Greece

Site Status

Medical Center of Athens

Marousi, , Greece

Site Status

Olympion Clinic

Pátrai, , Greece

Site Status

University General Hospital of Patras

Pátrai, , Greece

Site Status

Bioclinic Thessaloniki

Thessaloniki, , Greece

Site Status

Interbalkan Medical Center of Thessaloniki

Thessaloniki, , Greece

Site Status

St. Luke's Hospital

Thessaloniki, , Greece

Site Status

Papageorgiou General Hospital of Thessaloniki

Thessaloniki, , Greece

Site Status

Celan S.A.

Guatemala City, , Guatemala

Site Status

INTEGRA Cancer Institute

Guatemala City, , Guatemala

Site Status

Oncomedica

Guatemala City, , Guatemala

Site Status

Grupo Medico Angeles

Guatemala City, , Guatemala

Site Status

Clínica Médica Especializada en Hematología

Guatemala City, , Guatemala

Site Status

Queen Mary Hospital

Hong Kong, , Hong Kong

Site Status

Tuen Mun Hospital

Hong Kong, , Hong Kong

Site Status

Semmelweis Egyetem

Budapest, , Hungary

Site Status

Tolna Megyei Balassa János Kórház

Budapest, , Hungary

Site Status

Budapesti Uzsoki Utcai Kórház

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont

Debrecen, , Hungary

Site Status

Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz

Miskolc, , Hungary

Site Status

Szent Borbala Korhaz

Tatabánya, , Hungary

Site Status

Zala Megyei Szent Rafael Korhaz

Zalaegersteg, , Hungary

Site Status

HCG City Cancer Centre

Vijayawada, Andhra Pradesh, India

Site Status

State Cancer Institute, Indira Gandhi Institute of Medical Sciences (IGIMS)

Patna, Bihar, India

Site Status

Nirmal Hospital

Surat, Gujarat, India

Site Status

Kiran Hospital Multi Super Speciality Hospital and Research Center

Surat, Gujarat, India

Site Status

Himalaya Cancer Hospital & Research Institute

Vadodara, Gujarat, India

Site Status

Kailash Cancer Hospital and Research Center

Vadodara, Gujarat, India

Site Status

KLES Dr Prabhakar Kore Hospital and Medical Research Centre

Belagavi, Karnataka, India

Site Status

Sujan Surgical Cancer Hospital And Amravati Cancer Foundation

Amravati, Maharashtra, India

Site Status

Kolhapur Cancer Centre

Kolhāpur, Maharashtra, India

Site Status

Tata Memorial Hospital

Mumbai, Maharashtra, India

Site Status

Government Medical College

Nagpur, Maharashtra, India

Site Status

Shalinitai Meghe Medical College and Hospital

Nagpur, Maharashtra, India

Site Status

HCG Manavata Cancer Centre

Nashik, Maharashtra, India

Site Status

Chopda Medicare & Research Centre pvt. Ltd

Nashik, Maharashtra, India

Site Status

Apex Wellness Hospital

Nashik, Maharashtra, India

Site Status

Sahyadri Speciality Hospital

Pune, Maharashtra, India

Site Status

Sahyadri Super Specialty Hospital Hadapsar

Pune, Maharashtra, India

Site Status

Lokmanya Holistic Cancer Care and Research Center (LMRC)

Pune, Maharashtra, India

Site Status

Erode Cancer Centre

Erode, Tamil Nadu, India

Site Status

Christian Medical College-Ranipet Campus

Ratnagiri Kilminnal, Tamil Nadu, India

Site Status

Cork University Hospital

Cork, , Ireland

Site Status

Bon Secours Hospital

Cork, , Ireland

Site Status

St Vincents University Hospital

Dublin, , Ireland

Site Status

Beaumont Hospital

Dublin, , Ireland

Site Status

Galway University Hospital

Galway, , Ireland

Site Status

Mid- Western Regional Hospital Limerick

Limerick, , Ireland

Site Status

Waterford Regional Hospital

Waterford, , Ireland

Site Status

Soroka University Medical Centre

Beersheba, , Israel

Site Status

Sheba Medical Center - PPDS

Ramat Gan, , Israel

Site Status

Tel-Aviv Sourasky Medical Center

Tel Aviv, , Israel

Site Status

Azienda Ospedaliera di Rilievo Nazionale e di Alta Specialita San Giuseppe Moscati

Avellino, Campania, Italy

Site Status

Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale

Napoli, Campania, Italy

Site Status

IRCCS Azienda Ospedaliero Universitaria di Bologna

Bologna, Emilia-Romagna, Italy

Site Status

Arcispedale Santa Maria Nuova

Reggio Emilia, Emilia-Romagna, Italy

Site Status

Fondazione Policlinico Universitario A Gemelli

Roma, Emilia-Romagna, Italy

Site Status

Ospedale San Raffaele S.r.l. - PPDS

Milan, Lombardy, Italy

Site Status

ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda Ca' Granda

Milan, Lombardy, Italy

Site Status

Istituto Clinico Humanitas

Rozzano (MI), Lombardy, Italy

Site Status

Ospedale San Giuseppe

Empoli, Tuscany, Italy

Site Status

Azienda Ospedaliera Universitaria Careggi

Florence, Tuscany, Italy

Site Status

Azienda Usl Toscana nord ovest - Ospedali Riuniti di Livorno

Livorno, Tuscany, Italy

Site Status

Azienda Ospedaliero Universitaria Pisana

Pisa, Tuscany, Italy

Site Status

IRCCS Ospedale Sacro Cuore Don Calabria

Negrar, Veneto, Italy

Site Status

Fukushima Medical University Hospital

Fukushima, , Japan

Site Status

Hiroshima University Hospital

Hiroshima, , Japan

Site Status

Social Medical Corporation Hakuaikai Sagara Hospital

Kagoshima, , Japan

Site Status

Tokai University Hospital

Kanagawa, , Japan

Site Status

Saitama Cancer Center

Kitaadachi-gun, , Japan

Site Status

Kumamoto University Hospital

Kumamoto-Shi Chuo-Ku, , Japan

Site Status

Nahanishi Clinic

Naha, , Japan

Site Status

National Hospital Organization Osaka National Hospital

Osaka, , Japan

Site Status

Osaka International Cancer Institute

Osaka, , Japan

Site Status

National Hospital Organization Hokkaido Cancer Center

Sapporo, , Japan

Site Status

St. Luke's International Hospital

Tokyo, , Japan

Site Status

The Cancer Institute Hospital of Japanese Foundation For Cancer Research

Tokyo, , Japan

Site Status

International Cancer Institute (ICI)

Eldoret, , Kenya

Site Status

The Aga Khan University-Kenya.

Nairobi, , Kenya

Site Status

Pauls Stradins Clinical University Hospital

R?ga, , Latvia

Site Status

Hospital Kuala Lumpur

Kuala Lumpur, FED. Territory of Kuala Lumpur, Malaysia

Site Status

University Malaya Medical Centre

Kuala Lumpur, FED. Territory of Kuala Lumpur, Malaysia

Site Status

National Cancer Institute IKN

Putrajaya, Federal Territory of Putrajaya, Malaysia

Site Status

Pantai Hospital Sungai Petani

Sungai Petani, Kedah, Malaysia

Site Status

Hospital Pulau Pinang

George Town, Pulau Pinang, Malaysia

Site Status

Sarawak General Hospital

Buzia?, Sarawak, Malaysia

Site Status

Beacon International Specialist Centre

Petaling Jaya, Selangor, Selangor, Malaysia

Site Status

Centro de Investigación en Artritis y Osteoporosis - PPDS

Mexicali, Estado de Baja California, Mexico

Site Status

Dr. José Luis González Trujillo

León, Guanajuato, Mexico

Site Status

Hospital Civil Fray Antonio Alcalde

Guadalajara, Jalisco, Mexico

Site Status

Health Pharma Professional Research

Mexico City, Mexico CITY (federal District), Mexico

Site Status

Clínica Integral Internacional de Oncología S de RL de CV

Puebla City, Mexico CITY (federal District), Mexico

Site Status

Accelerium S. de R.L. de C.V.

Monterrey, Nuevo León, Mexico

Site Status

Hospital Universitario Dr. Jose Eleuterio Gonzalez

Monterrey, Nuevo León, Mexico

Site Status

Centro de Investigacion Clinica de Oaxaca

Oaxaca City, Oaxaca, Mexico

Site Status

Investigación Médica de Alta Especialidad

Querétaro City, Querétaro, Mexico

Site Status

Neurociencias Estudios Clinicos S.C.

Culiacán, Sinaloa, Mexico

Site Status

Merida | Investigacion Clinica

Mérida, Yucatán, Mexico

Site Status

Centro de Investigacion Medica Aguascalientes

Aguascalientes, , Mexico

Site Status

Centro Oncologico Alianza XXI

México, , Mexico

Site Status

Oaxaca Site Management Organization

Oaxaca City, , Mexico

Site Status

Oncologica de Puebla S.A de C.V

Puebla City, , Mexico

Site Status

Oncológico Potosino

San Luis Potosí City, , Mexico

Site Status

Centro Hemato-Oncologico Privado CHOP

Toluca, , Mexico

Site Status

Catharina Hospital

Eindhoven, , Netherlands

Site Status

Hagaziekenhuis

The Hague, , Netherlands

Site Status

Viecuri Medisch Centrum

Venlo, , Netherlands

Site Status

PHI Clinical Hospital Dr Trifun Panovski Bitola

Bitola, , North Macedonia

Site Status

Acibadem Sistina Hospital

Skopje, , North Macedonia

Site Status

PHI University Clinic of Radiotherapy and Oncology

Skopje, , North Macedonia

Site Status

Clinica San Antonio;Investigaciones Trujillo S.A.C.

Trujillo, La Libertad, Peru

Site Status

Hospital Nacional Daniel A Carrion

Bellavista, , Peru

Site Status

Hospital Militar Central

Jesus Maria, , Peru

Site Status

Hospital Central Fuerza Aerea Del Peru

Lima, , Peru

Site Status

Clínica Santa Beatriz

Lima, , Peru

Site Status

Oncologia S.A.C. - Instituto Peruano de Oncología & Radioterapia

Lima, , Peru

Site Status

Oncosalud Sac

Lima, , Peru

Site Status

Saint Louis University Hospital of Sacred Heart

Baguio City, Benguet, Philippines

Site Status

University of Santo Tomas Hospital

Manila, National Capital Region, Philippines

Site Status

Riverside Medical Center, Inc.

Bacolod City, Western Visayas (Region VI), Philippines

Site Status

Baguio General Hospital and Medical Center

Baguio City, , Philippines

Site Status

Metro Davao Medical and Research Center

Davao City, , Philippines

Site Status

Cardinal Santos Medical Center

Manila, , Philippines

Site Status

The Medical City

Pasig, , Philippines

Site Status

East Avenue Medical Center

Quezon City, , Philippines

Site Status

St. Luke's Medical Center - Quezon City

Quezon City, , Philippines

Site Status

Centrum Onkologii im. Prof. F. Lukaszczyka w Bydgoszczy

Bydgoszcz, , Poland

Site Status

Szpital Morski Im. Pck

Gdynia, , Poland

Site Status

Narodowy Instytut Onkologii im. M.Sk?odowskiej-Curie - Pa?stwowy Instytut Badawczy Oddzia? Gliwice

Gliwice, , Poland

Site Status

Regionalny Szpital Specjalistyczny im. W. Bieganskiego

Grudziądz, , Poland

Site Status

Narodowy Instytut Onkologii - Panstwowy Instytut Badawczy, Oddzia? w Krakowie

Krakow, , Poland

Site Status

Centrum Terapii Wspolczesnej

Lodz, , Poland

Site Status

Centrum Onkologii Ziemi LUBELSKIEJ im. Sw Jana z Dukli, I oddz. Chemioterapii

Lublin, , Poland

Site Status

Centrum Medyczne Pratia

Poznan, , Poland

Site Status

Unidade Local de Saude de Santa Maria, E.P.E. - Hospital de Santa Maria

Lisbon, Lisbon District, Portugal

Site Status

Hospital Senhora da Oliveira ? Guimaraes, E.P.E

Guimarães, , Portugal

Site Status

Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E.

Lisbon, , Portugal

Site Status

Champalimaud Cancer Center

Lisbon, , Portugal

Site Status

Hospital da Luz

Lisbon, , Portugal

Site Status

Hospital Beatriz Angelo

Loures, , Portugal

Site Status

Centro Hospitalar do Porto ? Hospital de Santo António

Porto, , Portugal

Site Status

Instituto Portugues de Oncologia Do Porto Francisco Gentil Epe

Porto, , Portugal

Site Status

Centro Hospitalar de Vila Nova de Gaia / Espinho E.P.E

Vila Nova de Gaia, , Portugal

Site Status

Centro Hospitalar Trás Os Montes E Alto Douro EPE

Vila Real, , Portugal

Site Status

Spitalul Clinic de Obstetrica si Ginecologie Filantropia

Bucure?ti, , Romania

Site Status

Prof Dr I Chiricuta Institute of Oncology

Cluj-Napoca, , Romania

Site Status

Medisprof SRL

Cluj-Napoca, , Romania

Site Status

Oncology Center Sf. Nectarie

Craiova, , Romania

Site Status

Onco Clinic Consult SA

Craiova, , Romania

Site Status

Institutul Regional de Oncologie Iasi

Iași, , Romania

Site Status

Timisoara Emergency County Clinical Hospital

Timi?oara, , Romania

Site Status

Institute for Oncology and Radiology of Serbia

Belgrade, , Serbia

Site Status

University Hospital Medical Center Bezanijska kosa

Belgrade, , Serbia

Site Status

Oncology Institute of Vojvodina

Kamenitz, , Serbia

Site Status

Health Center Kladovo

Kladovo, , Serbia

Site Status

General Hospital Djordje Joanovic - Zrenjanin

Zrenjanin, , Serbia

Site Status

Univerzitna nemocnica s poliklinikou Milosrdni bratia spol s r o

Bratislava, , Slovakia

Site Status

Onkologicky ustav sv. Alzbety, s.r.o.

Bratislava, , Slovakia

Site Status

Narodny onkologicky ustav

Bratislava, , Slovakia

Site Status

Vychodoslovensky onkologicky ustav

Košice, , Slovakia

Site Status

Institute of Oncology Ljubljana

Ljubljana, , Slovenia

Site Status

Cape Town Oncology Trials

Cape Town, , South Africa

Site Status

Cancercare Rondebosch Oncology

Cape Town, , South Africa

Site Status

WITS Clinical Research Site PPDS

City of Johannesburg, , South Africa

Site Status

Sandton Oncology Medical Group (Pty) Ltd

City of Johannesburg, , South Africa

Site Status

Excellentis Clinical Trial Consultants

George, , South Africa

Site Status

Medical Oncology Centre of Rosebank

Johannesburg, , South Africa

Site Status

Southern Cross Research South Africa (PTY) LTD

Mogale City, , South Africa

Site Status

Wilgers Oncology Centre

Pretoria, , South Africa

Site Status

Soon Chun Hyang University Cheonan Hospital

Cheonan-si, Chungcheongnam-do, South Korea

Site Status

Chungbuk National University Hospital

Cheongju-si, , South Korea

Site Status

Yonsei University Wonju Severance Christian Hospital

Gangwon-do, , South Korea

Site Status

National Cancer Centre

Gyeonggi-do, , South Korea

Site Status

CHA Bundang Medical Center

Gyeonggi-do, , South Korea

Site Status

Inha University Hospital

Incheon, , South Korea

Site Status

Gachon University Gil Medical Center

Namdong-Gu, , South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Asan Medical Center - PPDS

Seoul, , South Korea

Site Status

Gangnam Severance Hospital, Yonsei University Health System

Seoul, , South Korea

Site Status

Korea University Guro Hospital

Seoul, , South Korea

Site Status

Severance Hospital, Yonsei University Health System

Seoul, , South Korea

Site Status

The Catholic University of Korea Seoul St. Mary?s Hospital

Seoul, , South Korea

Site Status

Samsung Medical Center - PPDS

Seoul, , South Korea

Site Status

Ulsan University Hosiptal

Songpa-Gu, , South Korea

Site Status

Ajou University Hospital

Suwon, , South Korea

Site Status

Hospital General Universitario de Elche

Elche, Alicante, Spain

Site Status

Hospital Son Llatzer

Palma de Mallorca, Balearic Islands, Spain

Site Status

ICO Badalona-H.U. Germans Trias i Pujol

Badalona, Barcelona, Spain

Site Status

ALTHAIA Xarxa Assistencial de Manresa

Manresa, Barcelona, Spain

Site Status

Corporacio Sanitaria Parc Tauli

Sabadell, Barcelona, Spain

Site Status

Hospital Universitario Insular de Gran Canaria

Las Palmas de Gran Canaria, LAS Palmas, Spain

Site Status

Hospital Universitari Arnau de Vilanova

Lleida, Lerida, Spain

Site Status

Hospital Universitario Fundación Alcorcón

Alcorcón, Madrid, Spain

Site Status

Complejo Hospitalario de Navarra

Pamplona, Navarre, Spain

Site Status

CHUVI ? H.U. Alvaro Cunqueiro

Vigo, Pontevedra, Spain

Site Status

Hospital Nuestra Senora de Valme

Seville, Sevilla, Spain

Site Status

Hospital Universitario Virgen Macarena

Seville, Sevilla, Spain

Site Status

Hospital Universitari Sant Joan de Reus

Reus, Tarragona, Spain

Site Status

Hospital Universitario de Canarias

S. Cristobal de La Laguna, Tenerife, Spain

Site Status

Hospital Universitario Basurto

Bilbao, Vizcaya, Spain

Site Status

Complejo Hospitalario Universitario de Albacete

Albacete, , Spain

Site Status

Hospital General Universitario de Alicante

Alicante, , Spain

Site Status

Hospital Universitario San Juan

Alicante, , Spain

Site Status

Hospital Nuestra Señora de Sonsoles

Ávila, , Spain

Site Status

Hospital del Mar

Barcelona, , Spain

Site Status

Clinica Tres Torres

Barcelona, , Spain

Site Status

Hospital Universitario Quiron Dexeus

Barcelona, , Spain

Site Status

Hospital Clinic de Barcelona

Barcelona, , Spain

Site Status

Hospital de la Santa Creu i Sant Pau

Barcelona, , Spain

Site Status

Hospital Puerta del Mar

Cadiz, , Spain

Site Status

Hospital de San Pedro de Alcantara

Cáceres, , Spain

Site Status

Hospital General Universitario Reina Sofia

Córdoba, , Spain

Site Status

Institut Catala d'Oncologia Girona

Girona, , Spain

Site Status

Hospital Universitario Clínico San Cecilio

Granada, , Spain

Site Status

Hospital Universitario Virgen de Las Nieves

Granada, , Spain

Site Status

Hospital Universitario Juan Ramon Jimenez

Huelva, , Spain

Site Status

Hospital Universitario de Jaen

Jaén, , Spain

Site Status

Hospital General Universitario Gregorio Marañon

Madrid, , Spain

Site Status

IOB Madrid Institute of Oncology Hospital Beata Maria Ana de Jesus

Madrid, , Spain

Site Status

Hospital Universitario La Paz

Madrid, , Spain

Site Status

Clinica Universidad Navarra

Madrid, , Spain

Site Status

Hospital Universitario Infanta Leonor

Madrid, , Spain

Site Status

MD Anderson Cancer Center Madrid ? Espana

Madrid, , Spain

Site Status

Hospital Universitario Ramon y Cajal

Madrid, , Spain

Site Status

Hospital Clinico San Carlos

Madrid, , Spain

Site Status

Hospital Universitario Fundacion Jimenez Diaz.

Madrid, , Spain

Site Status

Hospital Universitario 12 De Octubre

Madrid, , Spain

Site Status

Hospital Universitario HM Sanchinarro ? CIOCC

Madrid, , Spain

Site Status

Hospital Universitario Puerta de Hierro - Majadahonda

Madrid, , Spain

Site Status

Hospital Universitario de Fuenlabrada

Madrid, , Spain

Site Status

Hospital Universitario Virgen de la Victoria

Málaga, , Spain

Site Status

Hospital General Universitario Morales Meseguer

Murcia, , Spain

Site Status

Hospital Universitario Virgen de La Arrixaca

Murcia, , Spain

Site Status

Hospital Universitario Son Espases

Palma de Mallorca, , Spain

Site Status

Hospital Universitario Virgen del Rocío

Seville, , Spain

Site Status

Fundacion Instituto Valenciano de Oncologia (IVO)

Valencia, , Spain

Site Status

Hospital Clinico Universitario de Valencia

Valencia, , Spain

Site Status

Consorcio Hospital General Universitario de Valencia

Valencia, , Spain

Site Status

Hospital Universitari i Politecnic La Fe de Valencia

Valencia, , Spain

Site Status

Hospital Clinico Universitario de Valladolid

Valladolid, , Spain

Site Status

Länssjukhuset Ryhov

Jönköping, , Sweden

Site Status

Södersjukhuset

Stockholm, , Sweden

Site Status

Sundsvalls sjukhus

Sundsvall, , Sweden

Site Status

Akademiska Sjukhuset

Uppsala, , Sweden

Site Status

Västmanlands sjukhus Västerås

Västerås, , Sweden

Site Status

Tumorzentrum Aarau

Aarau, , Switzerland

Site Status

Kantonsspital Baden

Baden, , Switzerland

Site Status

Universitätsspital Bern

Bern, , Switzerland

Site Status

Hirslanden Salem-Spital

Bern, , Switzerland

Site Status

Kantonsspital Graubünden KSGR

Chur, , Switzerland

Site Status

Luzerner Kantonsspital LUKS

Lucerne, , Switzerland

Site Status

Hirslanden Klinik St. Anna

Lucerne, , Switzerland

Site Status

Kantonsspital St. Gallen

Sankt Gallen, , Switzerland

Site Status

Spital STS AG Thun - Berner Oberland

Thun, , Switzerland

Site Status

Kantonsspital Winterthur Medizin Pneumologie

Winterthur, , Switzerland

Site Status

Changhua Christian Medical Foundation Changhua Christian Hospital

Changhua County, , Taiwan

Site Status

Hsin-Chu Branch of National Taiwan University Hospital

Hsinchu, , Taiwan

Site Status

Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung City, , Taiwan

Site Status

Taipei Medical University Shuang Ho Hospital

New Taipei City, , Taiwan

Site Status

China Medical University Hospital

Taichung, , Taiwan

Site Status

National Cheng Kung University Hospital

Tainan, , Taiwan

Site Status

Chi Mei Medical Cente

Tainan, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Chang Gung Memorial Hospital - Linkou

Taoyuan, , Taiwan

Site Status

Taichung Veterans General Hospital

Xitun Dist., , Taiwan

Site Status

Chulalongkorn Hospital

Bangkok, , Thailand

Site Status

Ramathibodi Hospital

Bangkok, , Thailand

Site Status

Siriraj Hospital, Mahidol University

Bangkok Noi, , Thailand

Site Status

Baskent Universitesi - Adana Uygulama Ve Arastirma Merkezi

Sariçam, Adana, Turkey (Türkiye)

Site Status

Hacettepe Universitesi Tip Fakultesi Hastanesi

Ankara, , Turkey (Türkiye)

Site Status

Ankara City Hospital

Ankara, , Turkey (Türkiye)

Site Status

Akdeniz University Medical Faculty

Antalya, , Turkey (Türkiye)

Site Status

Trakya University Medical Faculty

Edirne, , Turkey (Türkiye)

Site Status

Istanbul University Cerrahpasa Medical Faculty Hospital

Fat?h, , Turkey (Türkiye)

Site Status

T.C. Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin City Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Izmir Medical Point Hospital

Izmir, , Turkey (Türkiye)

Site Status

Katip Celebi University- Izmir Ataturk Egitim ve Arastirma Hastanesi

Izmir, , Turkey (Türkiye)

Site Status

Kocaeli Universitesi Tip Fakultesi Arastirma ve Uygulama Hastanesi

Kocaeli, , Turkey (Türkiye)

Site Status

Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi

Samsun, , Turkey (Türkiye)

Site Status

Ac?badem Adana Hospital, Oncology Department

Seyhan/Adana, , Turkey (Türkiye)

Site Status

Acibadem Altunizade Hospital

Üsküdar, , Turkey (Türkiye)

Site Status

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi

Yen?mahalle, , Turkey (Türkiye)

Site Status

Uganda Cancer Institute

Kampala, , Uganda

Site Status

St Francis Hospital Nsambya

Kampala, , Uganda

Site Status

Clinic Verum Expert LLC

Kyiv, KIEV Governorate, Ukraine

Site Status

Medical Clinical Research Center of Medical Center LLC Health Clinic

Vinnytsia, , Ukraine

Site Status

Royal Sussex County Hospital

Brighton, , United Kingdom

Site Status

Leicester Royal Infirmary

Leicester, , United Kingdom

Site Status

University College London Hospitals

London, , United Kingdom

Site Status

Nottingham City Hospital

Nottingham, , United Kingdom

Site Status

Royal Preston Hospital

Preston, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Austria Belgium Bosnia and Herzegovina Brazil Bulgaria Canada Chile China Colombia Costa Rica Croatia Czechia Egypt Finland France Georgia Germany Greece Guatemala Hong Kong Hungary India Ireland Israel Italy Japan Kenya Latvia Malaysia Mexico Netherlands North Macedonia Peru Philippines Poland Portugal Romania Serbia Slovakia Slovenia South Africa South Korea Spain Sweden Switzerland Taiwan Thailand Turkey (Türkiye) Uganda Ukraine United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-000129-28

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

2023-507172-44-00

Identifier Type: REGISTRY

Identifier Source: secondary_id

GO42784

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.